[go: up one dir, main page]

KR920009808A - 1,5-벤조티아제핀 유도체의 제조방법 - Google Patents

1,5-벤조티아제핀 유도체의 제조방법 Download PDF

Info

Publication number
KR920009808A
KR920009808A KR1019910021366A KR910021366A KR920009808A KR 920009808 A KR920009808 A KR 920009808A KR 1019910021366 A KR1019910021366 A KR 1019910021366A KR 910021366 A KR910021366 A KR 910021366A KR 920009808 A KR920009808 A KR 920009808A
Authority
KR
South Korea
Prior art keywords
hydroxy
benzothiazepine derivative
starting material
acetic acid
acetyl chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019910021366A
Other languages
English (en)
Other versions
KR0133056B1 (ko
Inventor
마사노리 요시오카
미쓰요시 와가쓰마
아키요시 요다
요시히사 야마다
군지 요시무라
Original Assignee
지바타 이치로
다나베 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지바타 이치로, 다나베 세이야쿠 가부시키가이샤 filed Critical 지바타 이치로
Publication of KR920009808A publication Critical patent/KR920009808A/ko
Application granted granted Critical
Publication of KR0133056B1 publication Critical patent/KR0133056B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

1,5-벤조티아제핀 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

1,3-하이드록시-2,3-디하이드록-5-[2-(디메틸아미노)에틸]-2-(P-메톡시페닐)-1,5-벤조티아제핀-4(5H)-온과 아세틸 클로라이드를 아세트산 또는 아세트산과 아세트산 무수물의 혼합용매 중에서 반응시킴을 특징으로 하여, 3-아세톡시-2,3-디하이드로-5-[2-디메틸아미노)에틸]-2-(p-메톡시페닐)-1,5-벤조티아제핀-4-(5H)-온의 하이드로클로라이드를 제조하는 방법.
제1항에 있어서, 출발물질인 3-하이드록시-1,5-벤조티아제핀 유도체 1몰당 아세틸 클로라이드 1 내지 20몰을 사용하는 방법.
제1항에 있어서, 출발물질인 3-하이드록시-1,5-벤조티아제핀 유도체 1몰당 아세틸 클로라이드 1.01 내지 10몰을 사용하여 아세트산 중에서 반응을 수행하는 방법.
제1항에 있어서, 출발물질인 3-하이드록시-1,5-벤조티아제핀 유도체 1몰당 아세틸 클로라이드 1 내지 5몰을 사용하여 아세트산과 아세트산 무수물의 혼합 용매 중에서 반응을 수행하는 방법.
제1항 내지 제4항중 어느 한항에 있어서, d-시스형태의 3-하이드록시-1,5-벤조티아제핀 유도체를 출발 물질에서 사용하는 방법.
※참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910021366A 1990-11-29 1991-11-27 1, 5-벤조티아제핀 유도체의 제조방법 Expired - Lifetime KR0133056B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33601090 1990-11-29
JP90-336010 1990-11-29

Publications (2)

Publication Number Publication Date
KR920009808A true KR920009808A (ko) 1992-06-25
KR0133056B1 KR0133056B1 (ko) 1998-04-17

Family

ID=18294763

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910021366A Expired - Lifetime KR0133056B1 (ko) 1990-11-29 1991-11-27 1, 5-벤조티아제핀 유도체의 제조방법

Country Status (15)

Country Link
US (1) US5169946A (ko)
EP (1) EP0488210B1 (ko)
JP (1) JPH0822856B2 (ko)
KR (1) KR0133056B1 (ko)
CN (1) CN1031342C (ko)
AT (1) ATE107638T1 (ko)
AU (1) AU634108B2 (ko)
DE (1) DE69102614T2 (ko)
DK (1) DK0488210T3 (ko)
ES (1) ES2059020T3 (ko)
FI (1) FI104173B1 (ko)
HK (1) HK174295A (ko)
HU (1) HU209830B (ko)
IE (1) IE914135A1 (ko)
IL (1) IL100157A (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705638A (en) * 1995-12-05 1998-01-06 Tanabe Seiyaku Co., Ltd. Process for preparing optically active 3-hydroxy-1,5-benzothiazepine derivative and intermediate therefor
EP0778272B1 (en) * 1995-12-05 1998-12-23 Tanabe Seiyaku Co., Ltd. Optically active benzothiazepine compounds and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
FR2360124A1 (fr) * 1976-07-30 1978-02-24 Amiens Const Electro Mecan Procede de controle de commutation de la puissance de chauffage dans un appareil electrodomestique a programmateur et dispositif pour la mise en oeuvre dudit procede
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
JPS62132876A (ja) * 1985-12-04 1987-06-16 Kohjin Co Ltd １，５−ベンゾチアゼピン誘導体の製法
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 １，５−ベンゾチアゼピン誘導体の製法

Also Published As

Publication number Publication date
EP0488210A1 (en) 1992-06-03
CN1062141A (zh) 1992-06-24
EP0488210B1 (en) 1994-06-22
IL100157A0 (en) 1992-08-18
ES2059020T3 (es) 1994-11-01
IL100157A (en) 1995-12-08
HU209830B (en) 1994-11-28
AU8825391A (en) 1992-06-04
FI104173B (fi) 1999-11-30
JPH0543564A (ja) 1993-02-23
US5169946A (en) 1992-12-08
DE69102614D1 (de) 1994-07-28
HK174295A (en) 1995-11-24
JPH0822856B2 (ja) 1996-03-06
DE69102614T2 (de) 1994-11-24
HUT61988A (en) 1993-03-29
CN1031342C (zh) 1996-03-20
AU634108B2 (en) 1993-02-11
FI915625A0 (fi) 1991-11-28
IE914135A1 (en) 1992-06-03
FI915625L (fi) 1992-05-30
KR0133056B1 (ko) 1998-04-17
HU913713D0 (en) 1992-02-28
ATE107638T1 (de) 1994-07-15
DK0488210T3 (da) 1994-08-01
FI104173B1 (fi) 1999-11-30

Similar Documents

Publication Publication Date Title
HU9502174D0 (en) Aminoacid derivatives, medicaments containing these compounds and process for preparing the same
ATE104962T1 (de) Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten.
DE69009964D1 (de) Verfahren zur Herstellung von 1-Phenylimidazolin-2,5-dion-Derivate.
NO822222L (no) Fremgangsmaate for fremstilling av pyrrolidinderivater
AU7554987A (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
KR920009808A (ko) 1,5-벤조티아제핀 유도체의 제조방법
NO175745C (no) Analogifremgangsmåte for fremstilling av dibenzo(1,5)-dioksocin-5-oner
KR900018012A (ko) 아실 시아나이드의 합성 방법
HUT71513A (en) 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them
ZA849159B (en) N-(methoxyphenacyl)-amine derivatives
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
BR8208033A (pt) Processo quimico
ATE182335T1 (de) ''steroidzwischenprodukte und verfahren zu ihrer herstellung''
DE69500362D1 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
ATE55611T1 (de) 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate.
DE69411387D1 (de) Verfahren zur Herstellung von pharmazeutisch aktiven Benzothiazepinderivaten.
DE68910931D1 (de) Verfahren zur Herstellung von Propionsäurederivaten.
GB2187186B (en) Butanedioic acid mono ((2-dimethylamino)ethyl ester)succinate
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
KR840006211A (ko) 가교 결합된 헥사하이드로벤즈[f]이소퀴놀린의 제조방법
ES2124102T3 (es) Procedimiento de sustitucion de ciclopentadieno.
JPS57169474A (en) 2-(4-benzyloxyphenyl)-3-acetoxy-5-(2-dimethylaminoethyl)- 2,3-dihydro-1,5-benzothiazepin-4(5h)-one and its preparation
MX9707150A (es) Uso de fumagilol y sus derivados para preparar medicamentos destinados a combatir las infecciones intestinales.
PT81192A (en) Process for preparing acetyldicarnitine dichloride and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19911127

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19950111

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19911127

Comment text: Patent Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19970926

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19971216

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19971216

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20001207

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20011205

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20021204

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20031204

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20041210

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20051208

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20061211

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20071207

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20081202

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20091210

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20101208

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20101208

Start annual number: 14

End annual number: 14

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20121009

Termination category: Expiration of duration